Brought to you by 
Astex, AstraZeneca enter CNS drug discovery collaboration
17 Sep 2014
Executive Summary
Astex Technology (structure-based drug discovery) and AstraZeneca entered an agreement to discover new drug candidates based on a target (implicated in Alzheimer's disease) that AstraZeneca will provide.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
-
Drug Discovery Tools
- Bioinformatics
- Genomics-Proteomics
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Astex, AstraZeneca enter CNS drug discovery collaboration
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice